WID-easy test launched in the UK – Great media response to the launch

The market launch of the WID?-easy test in the UK has attracted widespread media coverage over the past week. Numerous leading British media outlets, including The Guardian, The Times, The Telegraph and ITV News London have reported extensively on the launch of the innovative endometrial cancer detection test. These media reach millions of people and make the test known nationwide.

Positive tone and broad approval in the press

Reports on the new, minimally invasive test have been very positive. Patients and specialists have expressly praised it, as ITV News London reported. The main benefit: the test could save hundreds of thousands of women a year from painful procedures (UCL). The WID?-easy test is consistently highlighted and positively received in the media as a significant advance in women’s health.

Positive statements highlight company and test

Numerous media outlets picked up on statements from experts that cast Sola Diagnostics and the WID?-easy test in a positive light. Professor Martin Widschwendter, inventor of the test and founder of Sola Diagnostics, emphasized: “The WID?-easy test is the first test of its kind in the UK – using a simple swab method to detect womb cancer. We are proud to have developed a test that addresses an urgent gap in women’s health and performs well across all women” (ITV News London). This statement, quoted in several reports, underlines the many years of research and the innovative nature of the test.

Athena Lamnisos, CEO of the British foundation The Eve Appeal, also expressed her support. She emphasized how stressful the previous methods of testing can be for affected women and explained that a “less painful and more acceptable” alternative would be welcomed by many (The Telegraph). The WID?-easy test could “enable the many thousands of women who experience abnormal bleeding, and where cancer needs to be ruled out, to potentially avoid painful tests like a hysteroscopy and have their minds put at rest sooner, saving them from unnecessary stress” (The Telegraph).

Such appreciative voices from science and patient representatives characterize the media coverage and position the WID?-easy test as a significant advance in the diagnosis of endometrial cancer.

Reports focus on benefits for British women

All of the media reports clearly emphasized the specific benefits of the WID?-easy test for patients and conveyed the following key messages about the new test and its benefits for British women:

• Less invasive examination: Instead of a surgical procedure, a simple vaginal swab is sufficient – a much less stressful method than hysteroscopy and curettage (The Times).
• High accuracy: The test detects uterine cancer as reliably as an ultrasound scan (The Times).
• Fewer misdiagnoses: The number of false-positive results is reduced by 87%, allowing many women to avoid unnecessary follow-up examinations such as hysteroscopies or biopsies (UCL).
• Faster clarity: By eliminating the need for many invasive investigations, patients receive certainty more quickly in suspected cases – a psychological and physical relief (ITV News London).
• Suitable for all patient groups: The test provides reliable results regardless of ethnic background. WID?-easy offers a more precise alternative, especially for patients for whom ultrasound is less informative – for example women with certain pre-existing conditions or black skin color.

The reports also emphasize that the WID?-easy test has already been registered with the UK Medicines and Healthcare products Regulatory Agency (MHRA) and is now available in private clinics (ITV News London). In the medium term, there are hopes that this innovative test will also be widely used in the National Health Service (NHS) (The Telegraph). Overall, the media paint a picture of significant progress for women’s health: a simple, gentle test that is welcomed by experts and patients alike and has the potential to improve uterine cancer diagnostics in the UK in the long term.

Important media reports on the launch at a glance:

• The Guardian: “Swab test could help UK women avoid invasive checks for womb cancer” (Article from March 4, 2025) – Link to article
• The Times: “Simple swab test for womb cancer made available for UK patients” (article from March 4, 2025) – Link to article
• The Telegraph: “Covid-style tests for womb cancer to be offered” (article from March 4, 2025) – Link to article
• The Independent: “New womb cancer test to be used in the UK” (article from March 4, 2025) – Link to article
• ITV News London: “New less invasive cancer test by London doctors to check for womb cancer” (Article from March 5, 2025) – Link to article